LSC Recent Webinars on BIO

  1. Automating cell therapy manufacturing without redesigning established workflow 6/24/2026
  2. Automating Cell Therapy Manufacturing Without Redesigning Workflows 6/23/2026

    Cell therapy manufacturing teams face mounting pressure to automate without disrupting workflows. Learn how incremental automation can preserve process integrity and reduce risk.

  3. How Intensified Upstream Processing Improves Scale-Up And Tech Transfer 6/22/2026

    Intensified upstream processing can improve scalability and maintain quality. Learn how automation, PAT, and data-driven control strategies help modernize workflows and support consistent performance.

  4. Generate Stable High-Producing Clones In 14 Weeks 6/18/2026

    Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.

  5. Creative Chromatography Solutions For Complex Small Molecules 6/18/2026

    Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.

  6. Using Residual DNA Quantification Data To De-Risk mAb Development 6/11/2026

    Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.

  7. The AI Advantage For Regulated Manufacturing 6/10/2026

    Transitioning from paper batch records to human-centered AI optimizes pharma manufacturing. Learn to secure data, cut review times by 90%, and build a strong Return on Automation business case.

  8. Viral Safety Testing In Biologics: Detecting What Current Methods Miss 6/10/2026

    Biologics face unpredictable risks as complexity grows; evolving testing strategies to broaden detection, address gaps, and strengthen safety confidence without disrupting development or compliance.

  9. Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs 6/9/2026

    The goal is practical: help development teams make early decisions that balance speed, quality, and risk and support a smoother path to the clinic.

  10. From Gene Editing To NGS-Based T Cell Characterization 6/4/2026

    Gene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.